S&P 500   3,000.76 (+0.16%)
DOW   26,851.80 (+0.24%)
QQQ   192.05 (+0.10%)
AAPL   242.75 (+1.16%)
MSFT   136.05 (-0.23%)
GOOGL   1,255.76 (+1.17%)
AMZN   1,766.38 (+0.04%)
NVDA   194.64 (-0.50%)
MU   44.30 (-0.81%)
BABA   168.86 (-0.61%)
GE   9.03 (-0.44%)
TSLA   254.39 (-0.47%)
ACB   3.59 (+0.28%)
PRI   125.46 (-0.27%)
GILD   65.91 (+0.08%)
DIS   132.06 (-0.26%)
S&P 500   3,000.76 (+0.16%)
DOW   26,851.80 (+0.24%)
QQQ   192.05 (+0.10%)
AAPL   242.75 (+1.16%)
MSFT   136.05 (-0.23%)
GOOGL   1,255.76 (+1.17%)
AMZN   1,766.38 (+0.04%)
NVDA   194.64 (-0.50%)
MU   44.30 (-0.81%)
BABA   168.86 (-0.61%)
GE   9.03 (-0.44%)
TSLA   254.39 (-0.47%)
ACB   3.59 (+0.28%)
PRI   125.46 (-0.27%)
GILD   65.91 (+0.08%)
DIS   132.06 (-0.26%)
Log in

Cumberland Pharmaceuticals SEC Filings & 10K Form (NASDAQ:CPIX)

$5.40
0.00 (0.00 %)
(As of 10/23/2019 11:03 AM ET)
Today's Range
$5.36
Now: $5.40
$5.36
50-Day Range
$4.80
MA: $5.36
$5.98
52-Week Range
$4.70
Now: $5.40
$7.00
Volume44 shs
Average Volume24,774 shs
Market Capitalization$83.00 million
P/E RatioN/A
Dividend YieldN/A
Beta0.16

SEC Filings

Cumberland Pharmaceuticals (NASDAQ:CPIX) SEC Filings

DateFilerForm TypeView
10/18/2019
4:17 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
4:18 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
4:16 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
4:18 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
4:17 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
4:16 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
4:16 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
4:14 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
4:27 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
4:16 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
4:14 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
4:20 PM
Cumberland Pharmaceuticals (Issuer)
Pavliv Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
4:18 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
4:02 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:56 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
4:11 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
4:28 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
4:19 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:28 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:27 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
4:26 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
4:24 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
4:17 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
4:16 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:15 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:26 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:22 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:22 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:21 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:20 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:13 PM
Cumberland Pharmaceuticals (Issuer)
Pavliv Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:12 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
4:25 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:15 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:30 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
4:29 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
4:17 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
4:16 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
4:15 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
4:14 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:23 PM
Bonner Michael (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:23 PM
Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:22 PM
Cearnal Martin E (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:22 PM
Cumberland Pharmaceuticals (Issuer)
Pavliv Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:21 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:21 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:20 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:19 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:16 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:15 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
4:13 PM
Cumberland Pharmaceuticals (Issuer)
Griggs Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
4:21 PM
Cumberland Pharmaceuticals (Filer)
Form DEF 14A
02/26/2019
4:11 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
9:32 AM
ARIEL INVESTMENTS, LLC (Filed by)
Cumberland Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
3:02 PM
Cumberland Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/08/2019
4:06 PM
Cumberland Pharmaceuticals (Subject)
Form SC 13G
02/08/2019
6:13 AM
Cumberland Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
01/28/2019
4:24 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
7:21 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K/A
01/24/2019
4:30 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
1:44 PM
Cumberland Pharmaceuticals (Filer)
Form CT ORDER
12/07/2018
4:13 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
4:12 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
4:16 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:57 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
4:16 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2018
4:26 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
4:01 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/21/2018
4:16 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2018
4:19 PM
Bonner Michael (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:14 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
4:23 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:12 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2018
4:03 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
4:06 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2018
4:11 PM
Bonner Michael (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
4:06 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
4:05 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
3:59 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2018
4:46 PM
Cearnal Martin E (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:45 PM
Cumberland Pharmaceuticals (Issuer)
Pavliv Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:45 PM
Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:44 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:44 PM
Bernard Gordon R (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:43 PM
Cumberland Pharmaceuticals (Issuer)
Griggs Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:43 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:42 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:42 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:41 PM
Cumberland Pharmaceuticals (Issuer)
JACOBS JOEY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:40 PM
Bonner Michael (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2018
4:00 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2018
3:58 PM
Cumberland Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2018
3:55 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
4:04 PM
Cumberland Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/13/2018
9:01 AM
ARIEL INVESTMENTS, LLC (Filed by)
Cumberland Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2018
3:54 PM
Cumberland Pharmaceuticals (Subject)
Form SC 13G
02/09/2018
6:36 AM
Cumberland Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
01/16/2018
11:15 PM
Cumberland Pharmaceuticals (Filer)
Form EFFECT
12/22/2017
4:01 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2017
4:17 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel